Quarterly report pursuant to Section 13 or 15(d)

Note 10 - Operating Segments (Tables)

Note 10 - Operating Segments (Tables)

9 Months Ended

Sep. 30, 2016

Notes Tables

Schedule of Segment Reporting Information, by Segment [Table Text Block]

		Treatment				Services				Medical				Segments Total				Corporate (1)				Consolidated Total
Revenue from external customers		$	7,643			$	5,278				—			$	12,921			$	—			$	12,921
Intercompany revenues			28				8				—				36				—				—
Gross profit			837				970				—				1,807				—				1,807
Research and development			95				4				342				441				—				441
Interest income			—				—				—				—				31				31
Interest expense			(2	)			(2	)			—				(4	)			(97	)			(101	)
Interest expense-financing fees			—				—				—				—				(14	)			(14	)
Depreciation and amortization			1,019				161				—				1,180				9				1,189
Segment (loss) income before income taxes			(90	)			360				(342	)			(72	)			(1,391	)			(1,463	)
Income tax expense			35				—				—				35				2				37
Segment (loss) income			(125	)			360				(342	)			(107	)			(1,393	)			(1,500	)
Expenditures for segment assets			63				13				—				76				—				76

		Treatment				Services				Medical				Segments Total				Corporate (1)				Consolidated Total
Revenue from external customers		$	10,866			$	6,443				—			$	17,309			$	—			$	17,309
Intercompany revenues			32				7				—				39				—				—
Gross profit			3,696				1,250				—				4,946				—				4,946
Research and development			49				—				527				576				7				583
Interest income			4				—				—				4				12				16
Interest expense			(1	)			—				—				(1	)			(123	)			(124	)
Interest expense-financing fees			—				—				—				—				(56	)			(56	)
Depreciation and amortization			729				172				—				901				11				912
Segment income (loss) before income taxes			2,745				490				(527	)			2,708				(1,371	)			1,337
Income tax expense (benefit)			64				(17	)			—				47				6				53
Segment income (loss)			2,681				507				(527	)			2,661				(1,377	)			1,284
Expenditures for segment assets			58				15				—				73				—				73

		Treatment				Services				Medical				Segments Total				Corporate (1)				Consolidated Total
Revenue from external customers		$	22,832			$	14,936				—			$	37,768			$	—			$	37,768
Intercompany revenues			38				23				—				61				—				—
Gross profit			1,280				2,377				—				3,657				—				3,657
Research and development			321				38				1,196				1,555				15				1,570
Interest income			3				—				—				3				75				78
Interest expense			(19	)			(2	)			—				(21	)			(356	)			(377	)
Interest expense-financing fees			—				—				—				—				(99	)			(99	)
Depreciation and amortization			2,437				482				—				2,919				67				2,986
Segment (loss) income before income taxes			(11,895	)	(2)		682				(1,196	)			(12,409	)			(4,164	)			(16,573	)
Income tax (benefit) expense			(3,095	)	(2)		—				—				(3,095	)			2				(3,093	)
Segment (loss) income			(8,800	)			682				(1,196	)			(9,314	)			(4,166	)			(13,480	)
Expenditures for segment assets			86				17				1				104				—				104

		Treatment				Services				Medical				Segments Total				Corporate (1)				Consolidated Total
Revenue from external customers		$	31,702			$	15,562				—			$	47,264			$	—			$	47,264
Intercompany revenues			34				22				—				56				—				—
Gross profit			8,265				2,190				—				10,455				—				10,455
Research and development			137				—				1,354				1,491				9				1,500
Interest income			6				—				—				6				30				36
Interest expense			(34	)			—				—				(34	)			(356	)			(390	)
Interest expense-financing fees			—				(2	)			—				(2	)			(169	)			(171	)
Depreciation and amortization			2,236				552				—				2,788				33				2,821
Segment income (loss) before income taxes			5,259				248				(1,354	)			4,153				(4,351	)			(198	)
Income tax expense (benefit)			135				(17	)			—				118				6				124
Segment income (loss)			5,124				265				(1,354	)			4,035				(4,357	)			(322	)
Expenditures for segment assets			303				27				—				330				8				338